NIDB-3101

N/A

Report date: 2023/02/17 16:20:44

Base Information

Drug NameNIDB-3101
Drug Alias NameNI-3101NIDB-3101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLight Chain Bioscience Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInsysbio CY LtdDiscoveric Bio GroupLight Chain Bioscience Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A